Greenland Mines Ltd. Common Stock vs. Krystal Biotech, Inc. Common Stock
GRML
Greenland Mines Ltd. Common Stock
$8.74 -13.76%
VS KRYSKrystal Biotech, Inc. Common Stock
$346.58 +2.84%
Krystal Biotech, Inc. Common Stock (KRYS) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| GRML | KRYS | |
|---|---|---|
| Market Cap | $643,980 | $10.26 billion |
| Revenue (TTM) | — | $440.48 million |
| Net Income (TTM) | — | $241.47 million |
KRYS leads on 1 of 1 size & scale factors.
Valuation
| GRML | KRYS | |
|---|---|---|
| P/E Ratio | — | 43.43 |
| Price / Book | — | 7.55 |
| Price / Sales | — | 23.29 |
GRML and KRYS split the valuation factors evenly.
Profitability
| GRML | KRYS | |
|---|---|---|
| Net Margin | — | 54.82% |
| Return on Equity | — | 17.77% |
GRML and KRYS split the profitability factors evenly.
Risk & Sentiment
| GRML | KRYS | |
|---|---|---|
| Short Interest | 3.13% | 0.11% |
KRYS leads on 1 of 1 risk & sentiment factors.
Dig deeper: GRML overview, GRML financials, KRYS overview, KRYS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.